Deltanoid gets $12 million in financing (Wisconsin State Journal) Deltanoid Pharmaceuticals — the company formed by UW-Madison vitamin D expert Hector DeLuca to bring 2-MD, a bone-building drug, to market — is plunging ahead with two new drug compounds, thanks to a hefty infusion of cash. Local investors and venture firms have given Deltanoid $12 million in second-round financing to start human testing on the prospective drugs. One is aimed at controlling ... [News Source]